• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐药性艾滋病毒的母婴传播。

Mother-to-child transmission of drug-resistant HIV.

作者信息

Kijak G H, Avila M M, Salomón H

机构信息

National Center for AIDS, Department of Microbiology, School of Medicine, University of Buenos Aires, Argentina.

出版信息

Drug Resist Updat. 2001 Feb;4(1):29-37. doi: 10.1054/drup.2001.0182.

DOI:10.1054/drup.2001.0182
PMID:11512150
Abstract

Mother-to-child transmission of HIV-I is responsible for the infection of hundreds of thousands of infants every year. The use of prophylactic antiretroviral treatments has brought about a dramatic decrease in the risk of transmission. Nevertheless, vertical transmission can still occur. In some cases, the presence of drug-resistant HIV-I strains in the mother has been responsible for the failure of the prophylactic scheme. Moreover, these strains have also been detected in the newborn. The aim of this review is to provide updated information on mother-to-child transmission of drug-resistant HIV strains and to help guide treatment decisions during pregnancy.

摘要

每年,母婴传播导致成千上万的婴儿感染HIV-1。预防性抗逆转录病毒治疗的使用已大幅降低了传播风险。然而,垂直传播仍可能发生。在某些情况下,母亲体内耐药HIV-1毒株的存在导致了预防方案的失败。此外,在新生儿中也检测到了这些毒株。本综述的目的是提供关于耐药HIV毒株母婴传播的最新信息,并帮助指导孕期的治疗决策。

相似文献

1
Mother-to-child transmission of drug-resistant HIV.耐药性艾滋病毒的母婴传播。
Drug Resist Updat. 2001 Feb;4(1):29-37. doi: 10.1054/drup.2001.0182.
2
Genotypic resistance tests for the management of the HIV-infected pregnant woman.用于管理感染HIV的孕妇的基因型耐药性检测。
Scand J Infect Dis Suppl. 2003;106:70-4.
3
HIV-1 drug resistance and mother-to-child transmission.HIV-1耐药性与母婴传播。
SADJ. 2001 Dec;56(12):614-6.
4
Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV.孕妇HIV感染管理及预防HIV母婴传播指南。
HIV Med. 2005 Jul;6 Suppl 2:107-48. doi: 10.1111/j.1468-1293.2005.00302.x.
5
Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS.抗逆转录病毒药物——如何最好地保护婴儿免受艾滋病毒感染并使他们的母亲免于患艾滋病。
N Engl J Med. 2004 Jul 15;351(3):289-92. doi: 10.1056/NEJMe048128. Epub 2004 Jul 9.
6
Prevention of mother-to-child transmission of HIV: treatment options.预防母婴传播艾滋病毒:治疗方案。
Expert Rev Anti Infect Ther. 2005 Dec;3(6):971-80. doi: 10.1586/14787210.3.6.971.
7
Prevention of vertical transmission of HIV-1 in resource-limited settings.在资源有限的环境下预防 HIV-1 的垂直传播。
Expert Rev Anti Infect Ther. 2010 Oct;8(10):1163-75. doi: 10.1586/eri.10.94.
8
Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.治疗加速计划及“梦想”计划在预防艾滋病母婴传播方面的经验。
AIDS. 2007 Jul;21 Suppl 4:S65-71. doi: 10.1097/01.aids.0000279708.09180.f5.
9
Preventing mother-to-child transmission of HIV: successes and challenges.预防艾滋病母婴传播:成就与挑战
BJOG. 2005 Sep;112(9):1196-203. doi: 10.1111/j.1471-0528.2005.00716.x.
10
The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.撒哈拉以南非洲地区人类免疫缺陷病毒1型对抗逆转录病毒药物的耐药状况。
Antivir Ther. 2008;13(5):625-39.

引用本文的文献

1
Virulence and Replicative Fitness of HIV-1 Transmitted/Founder (T/F) Viruses Harbouring Drug Resistance-Associated Mutation.携带耐药相关突变的HIV-1传播/奠基(T/F)病毒的毒力和复制适应性
Viruses. 2024 Nov 29;16(12):1854. doi: 10.3390/v16121854.
2
Characterizing HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trial.在VESTED随机抗逆转录病毒治疗试验中对垂直传播病例的HIV耐药性进行特征分析。
J Acquir Immune Defic Syndr. 2024 Aug;96(4):385-392. doi: 10.1097/qai.0000000000003435.
3
Transient antiretroviral therapy selecting for common HIV-1 mutations substantially accelerates the appearance of rare mutations.
选择常见HIV-1突变的短暂抗逆转录病毒疗法会大幅加速罕见突变的出现。
Theor Biol Med Model. 2008 Nov 14;5:25. doi: 10.1186/1742-4682-5-25.
4
Cost-effectiveness of models for prevention of vertical HIV transmission - voluntary counseling and testing and choices of drug regimen.预防艾滋病病毒垂直传播模型的成本效益——自愿咨询检测及药物治疗方案的选择
Cost Eff Resour Alloc. 2005 Jul 18;3:7. doi: 10.1186/1478-7547-3-7.
5
Effectiveness of nevirapine and zidovudine in a pilot program for the prevention of mother-to-child transmission of HIV-1 in Uganda.奈韦拉平和齐多夫定在乌干达预防HIV-1母婴传播试点项目中的有效性。
Afr Health Sci. 2004 Dec;4(3):146-54.